SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus. Keywords : ['new emerge therapeutic class', 'type diabete mellitus', 'treatment', 'inhibitor'] Author : RK Ghosh 5
SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus. Keywords : ['new emerge therapeutic class', 'type diabete mellitus', 'treatment', 'inhibitor'] Author : RK Ghosh 5
SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus. Keywords : ['new emerge therapeutic class', 'type diabete mellitus', 'treatment', 'inhibitor'] Author : RK Ghosh 5
SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus. Keywords : ['new emerge therapeutic class', 'type diabete mellitus', 'treatment', 'inhibitor'] Author : RK Ghosh 5
A review of metallothionein isoforms and their role in pathophysiology. Keywords : ['metallothionein isoform', 'role', 'review', 'pathophysiology'] Author : N Thirumoorthy 5
A review of metallothionein isoforms and their role in pathophysiology. Keywords : ['metallothionein isoform', 'role', 'review', 'pathophysiology'] Author : N Thirumoorthy 5
A review of metallothionein isoforms and their role in pathophysiology. Keywords : ['metallothionein isoform', 'role', 'review', 'pathophysiology'] Author : N Thirumoorthy 5
A review of metallothionein isoforms and their role in pathophysiology. Keywords : ['metallothionein isoform', 'role', 'review', 'pathophysiology'] Author : N Thirumoorthy 5
Emerging role of dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin in the management of type 2 diabetes. Keywords : ['dipeptidyl peptidaseiv inhibitor vildagliptin', 'type diabete', 'emerge role', 'management'] Author : S Kalra 5
Emerging role of dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin in the management of type 2 diabetes. Keywords : ['dipeptidyl peptidaseiv inhibitor vildagliptin', 'type diabete', 'emerge role', 'management'] Author : S Kalra 5
